Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Creo Medical ( (GB:CREO) ) is now available.
Creo Medical Group PLC has announced a change in its major holdings, with M&G Plc increasing its voting rights from 10.12% to 11.51%. This acquisition of voting rights by M&G Plc signifies a strengthened position in the company, potentially impacting its strategic decisions and influencing shareholder dynamics.
More about Creo Medical
Creo Medical Group PLC operates in the medical technology industry, focusing on the development and commercialization of minimally invasive surgical devices. The company is known for its advanced energy platform, which is designed to improve patient outcomes and reduce surgical times.
Average Trading Volume: 1,579,809
Technical Sentiment Signal: Sell
Current Market Cap: £51.56M
For an in-depth examination of CREO stock, go to TipRanks’ Stock Analysis page.